Drug Markets/Dornase Alfa

Dornase Alfa

1 NDC across 1 manufacturer|0 Generic,1 Brand

Dornase Alfa is used to treat bronchitis and cystic fibrosis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $2 million on Dornase Alfa across 443 claims for 100 beneficiaries.

Dornase Alfa is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $53.16 to $53.16 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$53.16 – $53.16

per ML

7d Activity

1↑0 flat

avg +0.1% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing DORNASE ALFA

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
PULMOZYME 1 MG/ML AMPUL
$53.1569
per ML
+0.15%

Frequently Asked Questions

What is Dornase Alfa used to treat?

Dornase Alfa is used to treat bronchitis and cystic fibrosis, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Dornase Alfa?

In 2024, Medicare Part D spent $2 million on Dornase Alfa across 443 claims for 100 beneficiaries.

How many Dornase Alfa products are on the market?

The Dornase Alfa drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Dornase Alfa?

NADAC reference prices for Dornase Alfa range from $53.1569 to $53.1569 per ML.

Which manufacturers make Dornase Alfa?

1 manufacturer lists Dornase Alfa in NADAC. Ranked by number of NDCs, the largest are Genentech, Inc. (1).

How has the price of Dornase Alfa changed recently?

Over the past 7 days, 1 Dornase Alfa NDC rose and 0 fell, with a market-wide average change of +0.1%.